Tags: government + drugs.with.MS
-
An expert panel's advice that provinces and territories not cover the cost of two Multiple Sclerosis drugs creates a system of two-tiered care, MS advocates say.
-
Decision of the CEDAC (Canada) on the use of Tysabri (natalizumab)
-
A lack of funding has forced a Cardiff-based MS service to start a waiting list for patients who could benefit from beta interferon and copaxone.
-
Write your Representative today and ask them to support bio-generic drugs by including the Access to Life-Saving Medicine Act (H.R. 1038) with the re-authorization of PDUFA.
-
The money quietly paid to 46 Newfoundland and Labrador legislators in 2004 could have provided drugs for seven multiple sclerosis patients, a national organization says
-
Doctors in Canada can start prescribing Tysabri on Nov. 15 and patients will begin receiving monthly infusions in January.
-
Prosecutors are taking a firm line on the supply of cannabis for pain relief to people with chronically painful conditions such as multiple sclerosis, despite the downgrading of the drug from class B to class C.
First / Previous / Next / Last / Page 1 of 1